Rare diseases
Investigational molecules
Locations
Back to France1 417 clinical trials in Beuvry, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
FranceStudy on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
FranceStudy of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer
FranceStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
FranceStudy on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus
FranceStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
FranceStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
FranceStudy of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
FranceStudy Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
FranceStudy on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta
FranceStudy of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on gastrointestinal cancers, including studies evaluating novel treatments for esophageal squamous cell carcinoma and advanced colorectal cancer. Research includes innovative combination therapies and targeted treatments for specific genetic mutations.
Innovative studies examining treatments for non-small cell lung cancer, including immunotherapy combinations and radiation therapy approaches. Research focuses on improving outcomes for patients with advanced disease stages.
Comprehensive research into hormone-dependent cancers, investigating new treatment approaches for castrate-resistant prostate cancer and ER+/HER2- breast cancer. Studies include both early-stage and advanced disease management.
Studies examining treatments for respiratory tract infections and severe infections in intensive care settings. Research includes antibiotic alternatives and management strategies for septic shock.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
